| Literature DB >> 30619771 |
Yi Shao1, Zhaolai Hua2, Lei Zhao3, Yi Shen1, Xudong Guo1, Chen Niu1, Wenqiang Wei4, Fen Liu1.
Abstract
Background: Gastrointestinal (GI) cancers are the common cause of morbidity and mortality in China which seriously threaten people's health and lives. The aim of this study was to describe the temporal trend in the epidemiology of GI cancers from 1991 to 2015, with an emphasis on the effects of age, period and cohort in Yangzhong City, Jiangsu province, a high-risk area of GI cancers in China.Entities:
Keywords: age-period-cohort analysis; gastrointestinal cancers; incidence; mortality; trends
Year: 2018 PMID: 30619771 PMCID: PMC6306425 DOI: 10.3389/fonc.2018.00638
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Crude and age-standardized incidence and mortality rates (ASRs) of gastrointestinal cancers per 1,00,000 person-years in Yangzhong and calendar periods during 1991–2015.
| 1991–1995 | 1,301 | 189.28 | 156.76 | 797 | 114.88 | 90.90 | 702 | 102.13 | 86.79 | 469 | 67.60 | 51.47 |
| 1996–2000 | 1,133 | 164.85 | 138.39 | 706 | 101.82 | 79.74 | 856 | 124.55 | 106.71 | 538 | 77.59 | 57.35 |
| 2001–2005 | 1,238 | 180.24 | 128.81 | 682 | 97.65 | 64.60 | 818 | 119.09 | 86.18 | 460 | 65.86 | 42.18 |
| 2006–2010 | 1,210 | 177.28 | 106.76 | 647 | 92.47 | 51.93 | 496 | 72.67 | 43.65 | 244 | 34.87 | 18.59 |
| 2011–2015 | 1,122 | 162.33 | 82.81 | 564 | 78.71 | 37.05 | 650 | 94.04 | 46.56 | 274 | 38.24 | 16.27 |
| 1991–1995 | 696 | 101.26 | 81.89 | 746 | 107.53 | 85.84 | 399 | 58.05 | 47.41 | 430 | 61.98 | 47.79 |
| 1996–2000 | 741 | 107.82 | 87.76 | 735 | 106.00 | 83.40 | 515 | 74.93 | 63.23 | 526 | 75.86 | 57.18 |
| 2001–2005 | 809 | 117.78 | 83.90 | 700 | 100.23 | 65.09 | 509 | 74.11 | 53.42 | 467 | 66.87 | 40.82 |
| 2006–2010 | 820 | 120.14 | 72.42 | 617 | 88.18 | 49.36 | 331 | 48.50 | 29.54 | 239 | 34.16 | 17.75 |
| 2011–2015 | 752 | 108.80 | 55.05 | 491 | 68.52 | 30.27 | 422 | 61.05 | 30.19 | 275 | 38.38 | 15.55 |
| 1991–1995 | 88 | 12.80 | 10.60 | 91 | 13.12 | 9.93 | 41 | 5.96 | 4.88 | 44 | 6.34 | 4.25 |
| 1996–2000 | 115 | 16.73 | 13.55 | 104 | 15.00 | 11.72 | 56 | 8.15 | 7.18 | 57 | 8.22 | 6.03 |
| 2001–2005 | 142 | 20.67 | 14.83 | 120 | 17.18 | 11.21 | 78 | 11.36 | 8.25 | 63 | 9.02 | 5.66 |
| 2006–2010 | 206 | 30.18 | 17.98 | 150 | 21.44 | 12.44 | 75 | 10.99 | 6.54 | 46 | 6.57 | 3.33 |
| 2011–2015 | 289 | 41.81 | 22.18 | 194 | 27.07 | 13.59 | 108 | 15.63 | 7.96 | 74 | 10.33 | 4.38 |
| 1991–1995 | 88 | 12.80 | 10.60 | 91 | 13.12 | 9.93 | 41 | 5.96 | 4.88 | 44 | 6.34 | 4.25 |
ASR, age-standardized rates.
Figure 1Age-standardized incidence and mortality rates of gastrointestinal cancers by sex in Yangzhong, 1991–2015. (A) Age-standardized incidence rates of gastrointestinal cancers in males. (B) Age-standardized incidence rates of gastrointestinal cancers in females. (C) Age-standardized mortaity rates of gastrointestinal cancers in males. (D) Age-standardized mortaity rates of gastrointestinal cancers in females.
Joinpoint analysis of gastrointestinal cancers in Yangzhong, 1991–2015.
| Gastric cancer | Male | 1991–2015 | −3.0 (−3.6, −2.5) | < 0.01 | 1991–1993 | 54.4 (3.1, 131.2) | < 0.01 |
| 1993–2001 | 0.6 (−4.7, 6.2) | 0.8 | |||||
| 2001–2010 | −11.9 (−15.7, −8.0) | < 0.01 | |||||
| 2010–2015 | 9.5 (0.1,19.9) | < 0.01 | |||||
| Female | 1991–2015 | −4.5 (−5.2, −3.7) | < 0.01 | 1991–1999 | 7.0 (−0.3,14.7) | 0.1 | |
| 1999–2011 | −13.0 (−16.7,−9.1) | < 0.01 | |||||
| 2011–2015 | 11.3 (−9.1,36.3) | 0.3 | |||||
| Esophageal cancer | Male | 1991–2005 | 0.2 (−1.1, 1.6) | 0.7 | 1991–1993 | 49.0 (−1.9, 126.3) | 0.1 |
| 1993–2000 | 2.6 (−4.4, 10.1) | 0.4 | |||||
| 2005–2015 | −5.4 (−7.6, −3.3) | < 0.01 | 2000–2010 | −9.1 (−12.5, −5.6) | < 0.01 | ||
| 2010–2015 | 4.7 (−4.6,15.6) | 0.3 | |||||
| Female | 1991–2001 | −0.7 (−3.5, 2.1) | 0.6 | 1991–1993 | 66.3 (5.3,162.7) | < 0.01 | |
| 1993–2000 | 0.9 (−6.6,9.0) | 0.8 | |||||
| 2001–2015 | −7.7 (−9.3, −6.1) | < 0.01 | 2000–2010 | −13.9 (−17.4,−10.2) | < 0.01 | ||
| 2010–2015 | 4.5 (−5.7,15.7) | 0.4 | |||||
| Colorectal cancer | Male | 1991–2015 | 3.7 (2.2, 5.2) | < 0.01 | 1991–2015 | 2.3 (0.3, 4.4) | < 0.01 |
| Female | 1991–2015 | 1.5 (0.1, 3.0) | < 0.01 | 1991–1993 | 156.1 (−18.6, 705.9) | 0.1 | |
| 1993–2015 | −2.6 (−5.2, 0.1) | 0.1 | |||||
EAPC, estimated annual percent changes; CI, confidence interval.
Akaike information criterion (AIC) of age-period-cohort sub-models for gastrointestinal cancers incidence and mortality, Yangzhong, 1991–2015.
| Age-period-cohort | 7.98 | 7.24 | 7.57 | 6.71 | 7.35 | 7.15 | 6.71 | 6.18 | 5.95 | 5.75 | 4.96 | 4.61 |
| Age-drift | 769.17 | 714.42 | 887.73 | 813.44 | 631.20 | 993.02 | 606.14 | 762.33 | 334.17 | 276.28 | 232.42 | 227.31 |
| Age-period | 489.28 | 430.97 | 453.00 | 368.98 | 522.95 | 609.57 | 402.82 | 431.81 | 287.29 | 275.44 | 230.83 | 223.79 |
| Age-cohort | 397.51 | 357.08 | 477.74 | 405.07 | 375.58 | 363.76 | 397.99 | 346.10 | 291.91 | 282.57 | 244.66 | 233.77 |
Figure 2Age, period, and cohort effects on gastrointestinal cancers incidence and mortality with 95% confidence interval, stratified by sex. Footnotes: The age, period and cohort effects are estimated by a log-linear model using the intrinsic estimator (IE) method and expressed as rate ratios. (A–D) In the first row represent age effects after adjusting for period and cohort effects. (E–H) In the second row are the estimated period effects after adjusting for age and cohort effects. In the year 2004, a population-based endoscopy screening program in high-risk areas was initiated. (I–L) In the last row are the cohort effects after adjusting for age and period effects.
Highest cohort effects (Rate ratio) on GI cancers incidence and mortality rates and the corresponding birth cohorts.
| Incidence male | 1927 | 2.03 (1.79, 2.29) | 1942 | 1.77 (1.53, 2.06) | 1927 | 1.57 (1.18, 2.09) |
| Incidence female | 1927 | 1.71 (1.53, 1.91) | 1932 | 2.55 (2.10, 3.09) | 1927 | 1.30 (1.00, 1.70) |
| Mortality male | 1927 | 2.17 (1.89, 2.49) | 1937 | 2.32 (1.46, 3.71) | 1927 | 1.74 (1.20, 2.52) |
| Mortality female | 1927 | 2.11 (1.77, 2.52) | 1932 | 3.03 (1.91, 4.82) | 1932 | 1.76 (1.20, 2.59) |
CI, confidence interval.